Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

Urinary Incontinence: Economic Burden and New Choices in Pharmaceutical Treatment

In the year 2000, an estimated 17 million community-dwelling adults in the United States had daily urinary incontinence (UI) and an additional 33 million suffered from the overlapping condition, overactive bladder. Estimates of the total annual cost of these conditions range up to $32 billion; the largest components are management costs and the expenses associated with nursing home admissions attributable to UI. Until recently, pharmaceutical therapy for UI has been limited, especially because the adverse effects of available agents resulted in poor adherence to treatment regimens. Recent innovations in molecular design and new dosage forms of UI medications offer the promise of fewer and less severe adverse effects and, thus, better treatment outcomes for patients. New pharmacologic treatment options for UI have the potential to allow greater independence for older persons who reside at home and to delay or avoid the costs of admission to long-term care facilities.

Access to these new medications for patients enrolled in public and private health care plans also may help to reduce the economic and social burden of UI care.

Press Release

Improving Patient Outcomes and Costs in an ACO Through Comprehensive Medication Therapy Management

(Washington, DC, December 4, 2014)—A case study published in the December 2014 issue of the Journal of Managed Care & Specialty Pharmacy explores...
Blog Post

Specialty Pharmaceutical and Patient Care: Are We at a Tipping Point?

Last month, the Academy of Managed Care Pharmacy (AMCP) Foundation hosted a symposium, “Specialty Pharmaceutical and Patient Care: Are We at a...
Blog Post

#TBT: Health Care Quality Has Long Been an Important Issue

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...
Press Release

Fellowship in Health Care Policy Available Through a Partnership of the National Pharmaceutical Council and Milken Institute School of Public Health at The George Washington University

WASHINGTON, DC (September 17, 2014)–The National Pharmaceutical Council (NPC), in conjunction with Milken Institute School of Public Health (Milken...
Press Release

Improving Patient Outcomes and Costs in an ACO Through Comprehensive Medication Therapy Management

(Washington, DC, December 4, 2014)—A case study published in the December 2014 issue of the Journal of Managed Care & Specialty Pharmacy explores...
Press Release

Fellowship in Health Care Policy Available Through a Partnership of the National Pharmaceutical Council and Milken Institute School of Public Health at The George Washington University

WASHINGTON, DC (September 17, 2014)–The National Pharmaceutical Council (NPC), in conjunction with Milken Institute School of Public Health (Milken...
Press Release

Daiichi Sankyo CEO John Gargiulo Elected as National Pharmaceutical Council’s Chairman of the Board

WASHINGTON, DC (November 2, 2012)–The National Pharmaceutical Council (NPC) today announced that John Gargiulo, President & CEO, Daiichi Sankyo,...
Press Release

Study Quantifies Impact of Pharmaceuticals on Enhanced Productivity

(WASHINGTON, DC, August 1, 2012)–The costs to employers of chronic health conditions on employee productivity are well documented, but few studies...
Commentary and Testimony Page

Living Up to Its Name? The Role of Patient-Centered Research

Anyone who has ever received bad news from his or her health care provider or held a loved one’s hand when a diagnosis was delivered can understand...
Commentary and Testimony Page

High Stakes for Setting Research Standards

What is the cost of poorly designed research? In the comparative effectiveness arena, faulty studies could mean that consumers may make important...
Commentary and Testimony Page

Framework Helps ACOs Leverage Pharmaceuticals to Realize Quality, Cost Goals

Medications are more than an item on the balance sheet for health care providers. Pharmaceuticals offer a route to manage costs while achieving...
Commentary and Testimony Page

Asymmetry in the Ability to Communicate CER Findings: Ethics and Issues for Informed Decision Making

The number of voices in the comparative effectiveness research (CER) conversation is continuing to grow, but not all stakeholders have the same...
YouTube Videos

Engaging Consumers in Today's Changing Health Care Payment and Delivery Environment

The current health care delivery system is evolving from a fee-for-service system to one that is performance-based. How does this shift impact...
YouTube Videos

Shifting the Focus From "How Much" to "How Well" We Spend Our Health Care Dollars

A. Mark Fendrick, MD, director of the Center for Value-Based Insurance design at the University of Michigan, highlights the key findings from a...
YouTube Videos

Rapid-Learning Health Care Systems, Explained

Dr. Lucy Savitz, director of research and education, Institute for Healthcare Delivery Research, Intermountain Healthcare, explains rapid learning...
YouTube Videos

Ensuring Inclusive and Diverse Research

Andre Williams, CEO of the Association of Black Cardiologists explains that research should be inclusive and diverse, taking racial, ethnic and...
Blog Post

Specialty Pharmaceutical and Patient Care: Are We at a Tipping Point?

Last month, the Academy of Managed Care Pharmacy (AMCP) Foundation hosted a symposium, “Specialty Pharmaceutical and Patient Care: Are We at a...
Blog Post

#TBT: Health Care Quality Has Long Been an Important Issue

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...
Blog Post

#TBT: Senior Citizens Day & Individualized Pharmaceutical Care

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...
Blog Post

#TBT: Arthur Ashe & Medication Compliance

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...

Research

The Myth of Average: Why Individual Patient Differences Matter

Within today’s health care environment, so much of t

Imputing Productivity Gains From Clinical Trials

Researchers developed a new method to capture the impact that medicines may have on reducing the...
  •  
  • 1 of 42
  • >

Commentary & Testimony